Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
Community-based, Family-centered, Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
2 other identifiers
interventional
6,030
1 country
3
Brief Summary
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2023
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2023
CompletedFirst Posted
Study publicly available on registry
June 1, 2023
CompletedStudy Start
First participant enrolled
June 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
April 9, 2025
April 1, 2025
4.3 years
May 22, 2023
April 7, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in mean postpartum systolic blood pressure (SBP) at 6 weeks
Change in mean postpartum systolic blood pressure (SBP) at 6 weeks. A reduction in SBP indicates an improvement in postpartum hypertension.
6 weeks
Depression severity at 3 months postpartum assessed using the Edinburgh Postnatal Depression Scale (EPDS).
EPDS is a 10-item validated scale that measures depressive symptoms and is designed for use with pregnant and postpartum women. Scoring: None or minimal depression (0-6), Mild depression (7-13), Moderate depression (14-19), Severe depression (19-30). A reduction in depression severity at 3 months postpartum indicates a positive outcome.
3 months
Secondary Outcomes (1)
Participant engagement
6 weeks
Study Arms (3)
Standard of Care (SoC)
ACTIVE COMPARATORStandard of Care for Postpartum Hypertension
Remote Medical Model (RMM)
EXPERIMENTALIncludes SoC plus RMM
Community Health Model (CHM)
EXPERIMENTALIncludes SoC, RMM plus CHM
Interventions
Remote home blood pressure (BP) monitoring once a day for the first 7 days and then at least weekly or more frequently as per a standardized blood pressure protocol up to six weeks and weekly virtual visits for 6 weeks and up to 12 weeks as needed by a physician extender (e.g. Nurse Practitioner, Pharmacist, etc.), and screening for social determinants of health and anxiety/ depression with referral for services if positive
Utilization of community health workers trained in a strength-based trauma informed dyadic evidence-based approach.
SoC for Postpartum Hypertension
Eligibility Criteria
You may qualify if:
- Delivery of singleton live birth (twins reduced to singleton or with vanishing twin syndrome prior to 14 weeks qualify)
- Postpartum
- English or Spanish speaking
- Viable pregnancy 24 weeks of gestation or above (Child can be in NICU to participate)
- Medicaid or the equivalent within each state (for example, Connecticut has Husky insurance) or uninsured
- Must living in one of the three states involved in this study (Connecticut, Massachusetts, New York) and preferably within the geographical area of each of the hospitals
You may not qualify if:
- Multifetal pregnancy (since are they at increased risk for key outcomes)
- Gestational age \<24 weeks;
- Known major fetal anomaly in current pregnancy or stillbirth
- Actively using illicit/illegal substances (such as cocaine, heroin and other types of illicit opiates such as fentanyl) as noted in delivery hospitalization notes
- Active suicidal ideation with intent and plan
- Known primary psychotic disorder (i.e. schizophrenia, or schizoaffective disorder)
- Plans to move out of the state within 6 months
- Incapable of consent
- Severe medical complications that don't allow a mother to do the study effectively (for example, active treatment for cancer, dialysis etc. )
- Physician or provider refusal
- Patient refusal
- Incarcerated or institutionalized
- Stillbirth
- Births that result in the newborn being under the care of another person or institution other than the birthing individual (e.g. adoption, state involvement) will be evaluated on an individual basis to determine if that person should be included.
- For participants without access to a phone, we will explore if there are options that will allow them to have access to a devise for the times when they need to communicate with the study team. If not, they will not be able to participate in the study since this study requires phone or telehealth communication with research staff and/or APPs, and CHWs depending on study phase.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (3)
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
University of Massachusetts Memorial Health
Worcester, Massachusetts, 01655, United States
Oishei Children's Hospital University at Buffalo
Buffalo, New York, 14203, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Rafael Pérez-Escamilla, PhD
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2023
First Posted
June 1, 2023
Study Start
June 12, 2023
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
April 9, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share